Houston, TX February 20, 2025 - OmniScience is proud to announce that Angela Holmes, CEO and co-founder, has been nominated for the Women in AI Awards North America 2025. This prestigious recognition highlights the contributions of women driving AI innovation across Canada, the USA, and Mexico.
Women in AI (WAI) is a global nonprofit dedicated to fostering inclusive AI and supporting women and underrepresented groups in the field. Their annual awards celebrate the trailblazers who are shaping the future of AI through leadership, research, and real-world applications.
Angela’s nomination reflects her commitment to revolutionizing clinical trial operations through AI-driven innovation. Under her leadership, OmniScience has developed the industry’s first genAI system for clinical development reasoning, empowering biotech and pharma teams with real-time insights to accelerate clinical trials, reduce costs, and improve patient outcomes.
“I’m honored to be nominated for the Women in AI Awards North America,” said Holmes. “AI is transforming the way we approach clinical development, and it’s inspiring to be part of a community that champions innovation and inclusion in this space. Thank you Women in AI for this recognition!”
The Women in AI Awards North America will take place later this year, celebrating leaders who are advancing AI for the benefit of society.
